Pancreatic Ductal Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Ductal Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-07-14Clinical Trial Update: A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma [Phase 3]
Phase 3 trial evaluating PEGylated recombinant human hyaluronidase with nab-paclitaxel and gemcitabine versus placebo with nab-paclitaxel an…
-
CLINICAL_TRIALS trial_result · 2020-01-31Clinical Trial Update: A Phase II Study of Neoadjuvant FOLFIRINOX [Phase 2]
Phase II study of neoadjuvant FOLFIRINOX in resectable pancreatic ductal adenocarcinoma has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: PEGPH20, Gemicitabine and Nab-Paclitaxel for Pancreatic Ductal Adenocarcinoma [Phase 2]
Phase 2 clinical trial update for PEGPH20 with gemcitabine and nab-paclitaxel in pancreatic ductal adenocarcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2019-10-03Clinical Trial Update: Study of NAC of GA Therapy for Patients With BRPC [Phase 2]
Phase 2 clinical trial update for NAC of GA therapy in pancreatic ductal adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2019-08-14Clinical Trial Update: Phase Ib/II Study of MEDI4736 Evaluated in Different Combinations in Metastatic Pancreatic Ductal Carcinoma [Phase 1, Phase 2]
Phase Ib/II trial evaluating MEDI4736 (durvalumab) in various combinations for metastatic pancreatic ductal adenocarcinoma has completed pha…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-06-25Clinical Trial Update: Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating gemcitabine and nab-paclitaxel with Hedgehog inhibitor LDE-225 as neoadjuvant therapy for pancreatic ductal adeno…
-
CLINICAL_TRIALS trial_result · 2019-06-25Clinical Trial Update: A Study of Abemaciclib (LY2835219) Alone or in Combination With Other Agents in Participants With Previously Treated Pancreatic Ductal Adenocarcinoma [Phase 2]
Phase 2 clinical trial of abemaciclib (LY2835219) alone or with other agents in previously treated pancreatic ductal adenocarcinoma has comp…
-
CLINICAL_TRIALS trial_result · 2019-05-29Clinical Trial Update: Nab-Pac+Cis+Gem in Pts w Previously Untreated Metastatic PDA [Phase 1, Phase 2]
Clinical trial update for nab-paclitaxel + cisplatin + gemcitabine in previously untreated metastatic pancreatic ductal adenocarcinoma (stag…
-
CLINICAL_TRIALS trial_result · 2019-05-07Clinical Trial Update: Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC [Phase 2]
Phase 2 trial evaluating PEGPH20 in combination with pembrolizumab for second-line treatment of metastatic pancreatic ductal adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2019-02-18Clinical Trial Update: Modified FOLFIRINOX for Gemcitabine Refractory Pancreatic Cancer: A Phase II Multicenter Trial [Phase 2]
A Phase II multicenter trial evaluating a modified FOLFIRINOX regimen in gemcitabine-refractory pancreatic ductal adenocarcinoma has complet…
-
CLINICAL_TRIALS trial_result · 2019-02-04Clinical Trial Update: Ph1b/2 Study of PF-04136309 in Combination With Gem/Nab-P in First-line Metastatic Pancreatic Patients [Phase 2]
A Phase 1b/2 study of PF-04136309 in combination with gemcitabine and nab-paclitaxel in first-line metastatic pancreatic cancer was terminat…
-
CLINICAL_TRIALS trial_result · 2019-02-01Clinical Trial Update: Momelotinib Combined With Capecitabine and Oxaliplatin in Adults With Relapsed/Refractory Metastatic Pancreatic Ductal Adenocarcinoma [Phase 1]
Phase 1 clinical trial evaluating momelotinib in combination with capecitabine and oxaliplatin for relapsed/refractory metastatic pancreatic…
-
CLINICAL_TRIALS trial_result · 2018-10-01Clinical Trial Update: A Dose-Finding Study of Birabresib (MK-8628), a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Adults With Selected Advanced Solid Tumors (MK-8628-003) [Phase 1]
Phase 1 dose-finding study of birabresib (MK-8628), a BET inhibitor, completed with results posted in 2018 for selected advanced solid tumor…
-
CLINICAL_TRIALS trial_result · 2018-08-08Clinical Trial Update: Study of Gemcitabine, Abraxane® Plus Placebo Versus Gemcitabine, Abraxane® Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With 1st-Line Metastatic Pancreatic Ductal Adenocarcinoma [Phase 2]
Phase 2 trial evaluating gemcitabine and Abraxane plus placebo vs with demcizumab in first-line metastatic pancreatic ductal adenocarcinoma;…
-
CLINICAL_TRIALS trial_result · 2018-08-02Clinical Trial Update: Phase II Study of MEDI4736 Monotherapy or in Combinations With Tremelimumab in Metastatic Pancreatic Ductal Carcinoma [Phase 2]
Phase II study of MEDI4736 (durvalumab) alone or with tremelimumab in metastatic pancreatic ductal adenocarcinoma has completed with results…
-
CLINICAL_TRIALS trial_result · 2018-05-09Clinical Trial Update: Gemcitabine and Nab-paclitaxel Combined With Momelotinib in Participants With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma [Phase 3]
Phase 3 trial investigating gemcitabine and nab-paclitaxel with momelotinib in untreated metastatic pancreatic ductal adenocarcinoma was ter…
-
CLINICAL_TRIALS trial_result · 2018-04-20Clinical Trial Update: Study of SBP-101 in Pancreatic Cancer [Phase 1]
A Phase 1 study of SBP-101 in pancreatic cancer (ductal adenocarcinoma of the pancreas) conducted by Panbela Therapeutics has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-10Clinical Trial Update: Diagnostic Accuracy of Circulating Tumor Cells (CTCs) and Onco-exosome Quantification in the Diagnosis of Pancreatic Cancer - PANC-CTC
This completed clinical trial evaluated the diagnostic accuracy of circulating tumor cells (CTCs) and Onco-exosome quantification for diagno…
-
CLINICAL_TRIALS trial_result · 2018-02-27Clinical Trial Update: A Study Evaluating MM-310 in Patients With Solid Tumors [Phase 1]
This update reports a Phase 1 study evaluating MM-310 in patients with solid tumors. The listed indications include urothelial carcinoma, ga…
-
CLINICAL_TRIALS trial_result · 2018-02-07Clinical Trial Update: Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic Cancer [Phase 2]
A Phase 2 trial evaluating carboplatin and paclitaxel with or without viral therapy in patients with recurrent or metastatic pancreatic canc…
-
CLINICAL_TRIALS trial_result · 2018-01-18Clinical Trial Update: The Effects of Neoadjuvant Metformin on Tumour Cell Proliferation and Tumour Progression in Pancreatic Ductal Adenocarcinoma [Phase 2]
Phase 2 trial updating the effects of neoadjuvant metformin on tumour cell proliferation and progression in resectable pancreatic ductal ade…
-
CLINICAL_TRIALS trial_result · 2017-10-24Clinical Trial Update: Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer [Phase 3]
A Phase 3 clinical trial compares mesenteric approach versus conventional surgical approach for pancreatic ductal adenocarcinoma. The status…
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer [Phase 2]
This Phase II trial compared preoperative FOLFIRINOX versus gemcitabine/nab-paclitaxel in resectable pancreatic cancer; the study was termin…
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002 [Phase 2]
A Phase 2 clinical trial evaluating AGS-1C4D4 in pancreatic cancer patients previously treated in protocol 2008002 has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Continuous Monitoring on the General Ward [NA]
This is a completed clinical trial update from Radboud University Medical Center about continuous monitoring on the general ward. It lists p…